MEGHAN SIMPSON: Open Payments
NPI 1811371834 · FINDLAY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 42 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $65 · 2025 $934
Food & beverage: $934
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $234 |
| CSL Behring | 8 | $146 |
| Regeneron Healthcare Solutions, Inc. | 6 | $129 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $111 |
| AstraZeneca Pharmaceuticals LP | 4 | $91 |
| Grifols USA, LLC | 3 | $69 |
| Optinose US, Inc. | 3 | $67 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $38 |
| Greer Laboratories, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $22 |
Products named: Hizentra, DUPIXENT, Rhapsido, Xembify, Xhance, HYQVIA, AIRSUPRA, CUVITRU.
Industry payments across OH — which companies pay providers there.
